Glycemic control and survival of diabetic hemodialysis patients-Importance of lower hemoglobin A1C levels

Diabetes Research and Clinical Practice

Volumn 83, Issue 3, 2009, Pages 320-326

  Ishimura, E ^a   Okuno, S ^b   Kono, K ^b   Fujino Kato, Y ^b   Maeno, Y ^b   Kagitani, S ^b   Tsuboniwa, N ^b   Nagasue, K ^b   Maekawa, K ^b   Yamakawa, T ^b   Inaba, M ^a   Nishizawa, Y ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA CITY UNIVERSITY   (Japan)

Author keywords

Diabetic hemodialysis patients; Hemoglobin A1C; Mortality

Indexed keywords

HEMOGLOBIN A1C;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GLYCEMIC CONTROL; HEMODIALYSIS PATIENT; HEMOGLOBIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; SURVIVAL RATE;

AGED; BLOOD GLUCOSE; DIABETIC ANGIOPATHIES; DIABETIC NEPHROPATHIES; FEMALE; FOLLOW-UP STUDIES; HEMOGLOBIN A, GLYCOSYLATED; HOMEOSTASIS; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RENAL DIALYSIS; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 59449097934     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2008.11.038     Document Type: Article

References (33)

1. The Diabetes Control Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N. Engl. J. Med. 329 (1993) 977-986
2. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352 (1998) 837-853
3. Chiasson J.L., Josse R.G., Gomis R., Hanefeld M., Karasik A., and Laakso M. Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial. JAMA 290 (2003) 486-494
4. Gaede P., Vedel P., Larsen N., Jensen G.V., Parving H.H., and Pedersen O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N. Engl. J. Med. 348 (2003) 383-393
5. Wu M.S., Yu C.C., Yang C.W., Wu C.H., Haung J.Y., Hong J.J., et al. Poor pre-dialysis glycaemic control is a predictor of mortality in type II diabetic patients on maintenance haemodialysis. Nephrol. Dial. Transplant. 12 (1997) 2105-2110
6. Morioka T., Emoto M., Tabata T., Shoji T., Tahara H., Kishimoto H., et al. Glycemic control is a predictor of survival for diabetic patients on hemodialysis. Diabetes Care 24 (2001) 909-913
7. Okada T., Nakao T., and Matsumoto-H. Predialysis factors related to prognosis in type 2 diabetic patients on chronic dialysis in Japan. Nephrology (Carlton) 7 (2002) 250-256
8. Oomichi T., Emoto M., Tabata T., Morioka T., Tsujimoto Y., Tahara H., et al. Impact of glycemic control on survival of diabetic patients on chronic regular hemodialysis: a 7-year observational study. Diabetes Care 29 (2006) 1496-1500
9. Hayashino Y., Fukuhara S., Akiba T., Akizawa T., Asano Y., Saito A., et al. Diabetes, glycaemic control and mortality risk in patients on haemodialysis: the Japan Dialysis Outcomes and Practice Pattern Study. Diabetologia 50 (2007) 1170-1177
10. Fukuoka K., Nakao K., Morimoto H., Nakao A., Takatori Y., Arimoto K., et al. Glycated albumin levels predict long-term survival in diabetic patients undergoing haemodialysis. Nephrology (Carlton) 13 (2008) 278-283
11. Okada T., Nakao T., Matsumoto H., Shino T., Nagaoka Y., Tomaru R., et al. Association between markers of glycemic control, cardiovascular complications and survival in type 2 diabetic patients with end-stage renal disease. Intern. Med. 46 (2007) 807-814
12. Williams M.E., Lacson Jr. E., Teng M., Ofsthun N., and Lazarus J.M. Hemodialyzed type I and type II diabetic patients in the US: characteristics, glycemic control, and survival. Kidney Int. 70 (2006) 1503-1509
13. Kalantar-Zadeh K., Kopple J.D., Regidor D.L., Jing J., Shinaberger C.S., Aronovitz J., et al. A1C and survival in maintenance hemodialysis patients. Diabetes Care 30 (2007) 1049-1055
14. Okuno S., Ishimura E., Kitatani K., Fujino Y., Kohno K., Maeno Y., et al. Presence of abdominal aortic calcification is significantly associated with all-cause and cardiovascular mortality in maintenance hemodialysis patients. Am. J. Kidney Dis. 49 (2007) 417-425
15. Kakiya R., Shoji T., Tsujimoto Y., Tatsumi N., Hatsuda S., Shinohara K., et al. Body fat mass and lean mass as predictors of survival in hemodialysis patients. Kidney Int. 70 (2006) 549-556
16. Report of the Expert Committee on the diagnosis and classification of diabetes mellitus, Diabetes Care 20 (1997) 1183-1197.
17. Tanaka Y., Atsumi Y., Matsuoka K., Onuma T., Tohjima T., and Kawamori R. Role of glycemic control and blood pressure in the development and progression of nephropathy in elderly Japanese NIDDM patients. Diabetes Care 21 (1998) 116-120
18. Testa M.A., Simonson D.C., and Turner R.R. Valuing quality of life and improvements in glycemic control in people with type 2 diabetes. Diabetes Care 21 Suppl. 3 (1998) C44-C52
19. Friedman E.A. Advanced glycation end-products in diabetic nephropathy. Nephrol. Dial Transplant. 14 Suppl. 3 (1999) 1-9
20. The DECODE Study Group. European Diabetes Epidemiology Group. Diabetes Epidemiology: Collaborative analysis of Diagnostic criteria in Europe, Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria, Lancet 354 (1999) 617-621.
21. Khaw K.T., Wareham N., Bingham S., Luben R., Welch A., and Day N. Association of hemoglobin A1c with cardiovascular disease and mortality in adults: the European prospective investigation into cancer in Norfolk. Ann. Intern. Med. 141 (2004) 413-420
22. Selvin E., Coresh J., Golden S.H., Brancati F.L., Folsom A.R., and Steffes M.W. Glycemic control and coronary heart disease risk in persons with and without diabetes: the atherosclerosis risk in communities study. Arch. Intern. Med. 165 (2005) 1910-1916
23. Goldstein D.E., Little R.R., Lorenz R.A., Malone J.I., Nathan D., Peterson C.M., et al. Tests of glycemia in diabetes. Diabetes Care 27 (2004) 1761-1773
24. Little R.R., Tennill A.L., Rohlfing C., Wiedmeyer H.M., Khanna R., Goel S., et al. Can glycohemoglobin be used to assess glycemic control in patients with chronic renal failure?. Clin. Chem. 48 (2002) 784-786
25. Inaba M., Okuno S., Kumeda Y., Yamada S., Imanishi Y., Tabata T., et al. Glycated albumin is a better glycemic indicator than glycated hemoglobin values in hemodialysis patients with diabetes: effect of anemia and erythropoietin injection. J. Am. Soc. Nephrol. 18 (2007) 896-903
26. Ishimura E., Taniwaki H., Tabata T., Tsujimoto Y., Jono S., Emoto M., et al. Cross-sectional association of serum phosphate with carotid intima-medial thickness in hemodialysis patients. Am. J. Kidney Dis. 45 (2005) 859-865
27. Taniwaki H., Kawagishi T., Emoto M., Shoji T., Kanda H., Maekawa K., et al. Correlation between the intima-media thickness of the carotid artery and aortic pulse-wave velocity in patients with type 2 diabetes. Vessel wall properties in type 2 diabetes. Diabetes Care 22 (1999) 1851-1857
28. Taniwaki H., Shoji T., Emoto M., Kawagishi T., Ishimura E., Inaba M., et al. Femoral artery wall thickness and stiffness in evaluation of peripheral vascular disease in type 2 diabetes mellitus. Atherosclerosis 158 (2001) 207-214
29. Yokoyama H., Aoki T., Imahori M., and Kuramitsu M. Subclinical atherosclerosis is increased in type 2 diabetic patients with microalbuminuria evaluated by intima-media thickness and pulse wave velocity. Kidney Int. 66 (2004) 448-454
30. Khaw K.T., Wareham N., Luben R., Bingham S., Oakes S., Welch A., et al. Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of European prospective investigation of cancer and nutrition (EPIC-Norfolk). BMJ 322 (2001) 15-18
31. Turina M., Fry D.E., and Polk Jr. H.C. Acute hyperglycemia and the innate immune system: clinical, cellular, and molecular aspects. Crit. Care Med. 33 (2005) 1624-1633
32. Benfield T., Jensen J.S., and Nordestgaard B.G. Influence of diabetes and hyperglycaemia on infectious disease hospitalisation and outcome. Diabetologia 50 (2007) 549-554
33. Coughlin S.S., Calle E.E., Teras L.R., Petrelli J., and Thun M.J. Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults. Am. J. Epidemiol. 159 (2004) 1160-1167